Skip to main content

Table 1 Anamnestic and laboratory measurement data of type 1 diabetes patients

From: Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment

Variable Type 1 diabetes patients [n = 100] Age and sex matched controls [n = 62] p value
Age [years] 42.2 ± 13.4 44.1 ± 16.8 0.4443
Duration of diabetes [years] 17.3 ± 10.1
Chromogranin A [ng/mL]a 61.64 ± 55.27 48.03 ± 19.99 0.0348
Chromogranin B [ng/mL] 89.39 ± 34.23 107.38 ± 59.77 0.0241
HbA1C [%] 8.0 ± 1.7
HbA1C [mmol/mol] 64.0 ± 18.6
White blood cell count [109/L] 6.91 ± 1.77 7.08 ± 1.95 0.5894
Red blood cell count [1012/L] 4.88 ± 0.51 5.04 ± 0.56 0.0739
eGFR [mLmin−1(1.73m2)−1] 100.79 ± 18.65 100.26 ± 16.10 0.8483
Body mass index (BMI) [kg/m2] 25.6 ± 5.0 25.9 ± 5.3 0.7505
Sex (Female / Male) 50: 50 31: 31 1.0000
Hypertension 47 17 0.0140
Thyroid disease 31 4 0.0002
Gastroesophageal reflux disease 14 7 0.8104
Antacid therapy 6 5 0.7499
  1. Values are expressed as mean ± standard deviation, unit of anamnestic data is the number of observations
  2. eGFR Estimated glomerular filtration rate, HbA1C Glycated hemoglobin
  3. aExcluding the measurement of study subjects, who had any condition leading to chromogranin A elevation [3, 4, 7]. Remaining number of observations was 91 and 56, respectively